Cure My Disease

Don't miss your cure!

 Log in / Sign up

Hip replacement vs. metal rods: which surgery is better for bone cancer?

NCT ID NCT06863129

Disease control Sponsor: Michelle Ghert, MD Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jul 09, 2026 · Updated 2 times

Summary

This study looks at two types of hip surgery for people whose cancer has spread to the hip bone. One surgery removes the damaged bone and replaces it with an artificial joint. The other uses metal rods and plates to hold the bone together. The goal is to see which surgery leads to fewer problems, better physical function, and more time at home. About 334 adults with a life expectancy of at least 6 months will take part and be followed for one year.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 334 people

The number the study aims to enrol. It can still change while the study runs.

Started

Feb 2025

Expected to finish

Jun 2030

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Life expectancy of at least 6 months * Lesions in the proximal femur (femoral neck, intertrochanteric region, subtrochanteric region, and combinations thereof) * Low or intermediate risk for perioperative morbidity and/or mortality * No more than 75% and no less than 25% bone loss * Mutual (patient and physician) decision to perform surgical management of an impending or realized pathologic fracture due to MBD of the proximal has been made. Exclusion Criteria: * Lesions isolated to the femoral neck * Lesion with any femoral head involvement * High risk for perioperative morbidity and/or mortality * Multidisciplinary decision that resection of the entire lesion would be indicated

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Metastatic bone disease are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

bone disorder metastatic carcinoma in the bone metastatic neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Metastatic bone disease

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    7 sites in 4 countries. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Albany Medical Center

    ACTIVE_NOT_RECRUITING

    Albany, New York, 12206, United States

  • Foothills Medical Centre

    NOT_YET_RECRUITING

    Calgary, Alberta, Canada

  • Good Samaritan Regional Medical Center

    WITHDRAWN

    Corvallis, Oregon, 97330, United States

  • Hospital de Clínicas de Porto Alegre

    RECRUITING

    Porto Alegre, Rio Grande do Sul, 90450050, Brazil

  • Hôpital Maisonneuve-Rosemont

    WITHDRAWN

    Montreal, Quebec, H1T 2M4, Canada

  • McGill University Health Centre

    ACTIVE_NOT_RECRUITING

    Montreal, Quebec, H4A 3J1, Canada

  • Medical University Graz

    RECRUITING

    Graz, Austria

  • Mount Sinai Hospital

    ACTIVE_NOT_RECRUITING

    Toronto, Ontario, M5G 1X5, Canada

  • Oregon Health and Science University Hospital

    RECRUITING

    Portland, Oregon, 97239, United States

  • Parkview Packnett Family Cancer Institute

    RECRUITING

    Fort Wayne, Indiana, 46845, United States

  • University of Cincinnati Medical Center

    RECRUITING

    Cincinnati, Ohio, 45219, United States

  • University of Colorado Hospital

    RECRUITING

    Aurora, Colorado, 80045, United States

  • University of Maryland Medical Center

    ACTIVE_NOT_RECRUITING

    Baltimore, Maryland, 21201, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.